Do you mind if I forward this list to Larry Smith (Smith on Stocks)? It's thorough, well done, and shows key differences between the two device solutions.
Also and as an fyi: the Medac / BD Physioject device could be referred to as a market available subQ injector for any end user who wishes to enlist BD, enter an agreement and use.
Also, Bristol Myers Squibb is using the BD Physioject in this Ph 1 study for using "Abatacept (Orencia) is a drug used to treat inflammatory signs of arthritis, such as pain, swelling and prolonged joint stiffness. Abatacept belongs to the biologic class of drugs, which means that it works similarly to natural substances in the immune system.
Like other biologic drugs, abatacept was created with genetic-engineering techniques. It helps decrease inflammation in arthritis.
FAST FACTS Abatacept is a second-line drug that often is used when disease-modifying anti-rheumatic drugs, such as methotrexate, and/or other biologic drugs have failed to control inflammatory arthritis. No higher risk of serious infections was reported with abatacept compared to other biologic drugs. Further long-term studies are needed. Reports did not show higher risks of cancer in patients on abatacept. Larger study groups and long-term study will clarify this. Risks in pregnant women are still being studied."
News 
Market Data 
Discover 
AI
